A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors

Oncogene
L N KlapperM Sela

Abstract

ErbB-2 is an orphan receptor that belongs to a family of tyrosine kinase receptors for either epidermal growth factor (EGF) or Neu differentiation factor (NDF/neuregulin). Because overexpression of the erbB-2 proto-oncogene is frequently associated with an aggressive clinical course of certain human adenocarcinomas, the encoded protein is an attractive target for immunotherapy. Indeed, certain monoclonal antibodies (mAbs) to ErbB-2 effectively inhibit tumor growth in animal models and in clinical trials, but the underlying mechanism is incompletely understood. To study this question, we generated a large battery of mAbs to ErbB-2, that were classified epitopically. Whereas most antibodies stimulated tyrosine phosphorylation of ErbB-2, their anti-tumor effect correlated with its accelerated endocytic degradation. One group of tumor-inhibitory mAbs (Class II mAbs) was elicited by the most antigenic site of ErbB-2, and inhibited in trans binding of NDF and EGF to their direct receptors. The inhibitory effect was due to acceleration of ligand dissociation, and it resulted in the reduction of the ability of ErbB-2 to transactivate the mitogenic signals of NDF and EGF. These results identify two potential mechanisms of antibody-induc...Continue Reading

Citations

May 8, 2001·International Journal of Cancer. Journal International Du Cancer·M HouimelJ P Mach
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Abraham MittelmanDarja Kanduc
Oct 29, 2002·International Journal of Cancer. Journal International Du Cancer·Kwang-Mi KimChang-Yuil Kang
Jul 31, 1998·Protein Science : a Publication of the Protein Society·M Sela
Feb 22, 2008·Histochemistry and Cell Biology·Kirstine RoepstorffBo van Deurs
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Mina D MarmorYosef Yarden
Dec 26, 2001·Immunology Letters·Elena QuaglinoGuido Forni
Aug 1, 2000·Pharmaceutical Science & Technology Today·U B Nielsen, J D Marks
Jun 8, 2011·Nature Reviews. Neurology·Sylwia Ammoun, C Oliver Hanemann
Feb 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tsipi Ben-KasusMichael Sela
Sep 5, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ruth MaronMichael Sela
Jan 27, 2004·Molecular Biology of the Cell·Anette M HommelgaardBo van Deurs
Sep 24, 2004·Molecular Biology of the Cell·Cary D AustinRichard H Scheller
Aug 15, 1997·The EMBO Journal·E TzaharY Yarden
May 24, 2011·International Immunology·Esther J WitschMichael Sela
Apr 17, 2003·The Journal of Clinical Investigation·Claudia CurcioGuido Forni
Oct 4, 2006·BMC Immunology·Ulrik B NielsenJames D Marks
Aug 12, 1999·Biochemical and Biophysical Research Communications·W LiuR A Roth
Feb 13, 2001·Biochemical and Biophysical Research Communications·R M NeveC C Benz
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lilach M FriedmanYosef Yarden
Dec 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·T S WehrmanH M Blau
Apr 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·L N KlapperY Yarden
Feb 25, 2009·Expert Opinion on Therapeutic Targets·Elizabeth A Hopper-BorgeIgor Astsaturov
Jan 5, 2013·Expert Opinion on Biological Therapy·Divaya Bhutani, Ulka N Vaishampayan
Jul 5, 2005·Expert Opinion on Investigational Drugs·S Eccles
Jan 18, 2008·Journal of Pharmaceutical Sciences·Ales Prokop, Jeffrey M Davidson
Jun 16, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Agadha WickremesekeraAndrew H Kaye
Oct 30, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Agadha WickremesekeraAndrew H Kaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.